Joe Hammer was recently appointed to Chief Development Officer at Dohmen. Founded in 1858, Dohmen has evolved from an apothecary to a portfolio of companies, each serving a unique role in pursuit of Dohmen’s vision of creating an efficient, effective and easy to use health experience. For nearly two decades, Joe has worked with venture-backed start-ups to multi-billion dollar public companies. Most recently, as Managing Director of GE Capital’s Life Science Finance business, he developed and expanded relationships with early-stage medical device, biotechnology, diagnostics, and healthcare IT companies and their investors. His representative investments included: Assurex Health, Cerapedics, and Lumeris. Joe also is the Board Chair of BioForward, Wisconsin’s Biotechnology Industry Organization, AdvaMed, and PhRMA affiliate.